This document discusses methods for determining glomerular filtration rate (GFR) to assess kidney function. GFR is considered the best indicator of kidney function and is crucial for diagnosing and staging chronic kidney disease. GFR can be measured directly through clearance tests or estimated using formulas. New formulas have been developed to more accurately estimate GFR, but measurement remains the gold standard. Non-GFR factors like age, muscle mass, and medications can influence biomarkers like creatinine and cystatin C, so their levels must be properly interpreted. Standardizing assays and increasing awareness of non-GFR determinants can improve GFR assessment.
This document discusses methods for determining glomerular filtration rate (GFR) to assess kidney function. GFR is considered the best indicator of kidney function and is crucial for diagnosing and staging chronic kidney disease. GFR can be measured directly through clearance tests or estimated using formulas. New formulas have been developed to more accurately estimate GFR, but measurement remains the gold standard. Non-GFR factors like age, muscle mass, and medications can influence biomarkers like creatinine and cystatin C, so their levels must be properly interpreted. Standardizing assays and increasing awareness of non-GFR determinants can improve GFR assessment.
This document discusses methods for determining glomerular filtration rate (GFR) to assess kidney function. GFR is considered the best indicator of kidney function and is crucial for diagnosing and staging chronic kidney disease. GFR can be measured directly through clearance tests or estimated using formulas. New formulas have been developed to more accurately estimate GFR, but measurement remains the gold standard. Non-GFR factors like age, muscle mass, and medications can influence biomarkers like creatinine and cystatin C, so their levels must be properly interpreted. Standardizing assays and increasing awareness of non-GFR determinants can improve GFR assessment.
This document discusses methods for determining glomerular filtration rate (GFR) to assess kidney function. GFR is considered the best indicator of kidney function and is crucial for diagnosing and staging chronic kidney disease. GFR can be measured directly through clearance tests or estimated using formulas. New formulas have been developed to more accurately estimate GFR, but measurement remains the gold standard. Non-GFR factors like age, muscle mass, and medications can influence biomarkers like creatinine and cystatin C, so their levels must be properly interpreted. Standardizing assays and increasing awareness of non-GFR determinants can improve GFR assessment.
Download as PPTX, PDF, TXT or read online from Scribd
Download as pptx, pdf, or txt
You are on page 1of 15
DETERMINING THE
GLOMERULAR FILTRATION RATE
Review Article Elke Schaeffner, MD, MSc Journal of Renal Nutrition, Vol 27 No 6 (November), 2017
Andani Puspita Rani
1315244 Introduction • Glomerular Filtration Rate (GFR) is still considered the best indicator of kidney function worldwide • Exact assessment of GFR is crucial for several reasons: GFR determines the stage of chronic kidney disease (CKD), as the staging system is based on GFR • This staging system has several clinical implications, such as drug dosing, the application of potentially nephrotoxic contrast agents, the timing of renal replacement therapy, the appropriateness of living organ donation, and also the labeling of the diagnosis ‘‘CKD,’’ which has insurance (and therefore financial) and psychological implications cont.. • During the last 5 to 10 years, different groups have worked to optimize GFR assessment, which has led to a variety of publications about GFR estimation or measurement • In an endeavor to come as close as possible to the true GFR, several novel GFR estimation formulae (eGFR) have been developed • A huge body of literature also exists for GFR measuring (mGFR) methods which are supposed to be closer to the true GFR compared with the estimated and serve as ‘‘gold standards’’ whenever a new estimation formula is developed Measuring GFR • Measuring GFR is regarded as the more precise method for determining kidney function and is therefore frequently referred to as ‘‘gold standard.’’ • This gold standard method principally involves a clearance method. • The one that is still most often used in Germany is the creatinine clearance. In this case, urine is collected over a certain period of time—usually 24 hours (with 12 hours also being possible)—to record the urinary creatinine concentration. • Another, more precise option is the application of an intravenous exogenous filtration marker, with subsequent measurement of its plasma clearance (possibly in combination with the urinary clearance. • A distinction is made in a 2-compartment model between a ‘‘fast component’’ and a ‘‘slow component’’ phase, with the former corresponding to the ‘‘central’’ distribution of the marker in the blood and organs and the latter to its distribution in the peripheral areas (i.e., areas with less blood circulation, such as muscle or fatty tissue) and the renal elimination of the contrast medium from the blood Estimated GFR • An estimation formula that was only developed in sick people (e.g., Modification of Diet in Renal Disease [MDRD] study) underestimates GFR in healthy people. • Conversely, a formula that was principally developed in healthy people would overestimate GFR in sick people. Newer Estimation Formulae Non-GFR Determinants • Non-GFR determinants are factors that can influence endogenous biomarkers such as creatinine or cystatin C independently of GFR • For this reason, it is important to be aware of non-GFR determinants, so that GFR results can be better interpreted in certain clinical situations • Scenarios could be a normal creatinine but elevated cystatin C because of different causes: – That is, an elderly woman with low muscular mass who has CKD – patient being treated with chemotherapy for lymphoma. • In the first case, creatinine is dependent on muscle mass and thus not a suitable marker to detect reduced kidney function in this particular patient • In the second scenario, cystatin C is influenced (elevated) by the chemotherapy falsely suggesting impaired kidney function Standardization of Assays • Standardization of Assays The standardization of laboratory assays is extremely important when endogenous biomarkers such a creatinine and cystatin C are used. • Creatinin use an enzymatic method or isotope dilution mass spectrometry (IDMS traceable) or Colorimetric Jaffe method • Cystatin C use nephelometric Siemens assay corresponded to this standardization Conclusion • Kidney function can be determined using either estimation formulae or measuring methods • After being the primary filtration marker for decades, creatinine has now been joined by cystatin C in recent years • In this context, physicians should become more aware of the significance of ‘‘non-GFR determinants’’ for interpreting GFR values • Also worth mentioning are the new FAS formulae, which are being applied as the first formulae for all age categories, although they are still waiting for external validation before being used area-wide. • As a rule, laboratories should only use standardized assays, even if this reality is still in the distant future. Thank You